The retail price of taletrectinib is affected by factors such as region, medical insurance policies and purchasing channels, generally ranging from 720 to 2,160 US dollars per month. The actual selling price shall be subject to that of hospitals or formal pharmacies. As a prescription drug, its use must be strictly under the guidance of a doctor, and self-purchase or dosage adjustment is prohibited.
Main Factors Affecting the Price
Regional Differences
Pricing policies, taxation and circulation costs vary across different countries or regions. For example, the drug may be covered by medical insurance in some regions, leading to a significant reduction in patients' out-of-pocket expenses.
Drug Specifications
The price per box is influenced by dosage and packaging specifications (such as the number of tablets per box), and the selection should be based on the treatment plan.
Medical Insurance and Subsidies
If the drug is included in local medical insurance or charitable drug donation programs, the cost borne by patients may be greatly reduced. It is advisable to consult local medical institutions for specific policies.
Recommendations for Obtaining Accurate Pricing
Hospital Pharmacy
The attending physician or hospital pharmacy can provide the latest price information and medication regimens.
Formal Channels
Purchase through public medical institutions or authorized pharmacies to avoid the quality risks of drugs from informal channels.
Medical Insurance Inquiry
Contact the local medical insurance department to learn about the reimbursement ratio and relevant application procedures.
Precautions for Medication Use
Strictly follow medical advice
Taletrectinib is suitable for patients with lung cancer carrying specific gene mutations. Its applicability must be confirmed through genetic testing, and side effects such as fatigue and edema may occur during use.
Regular re-examinations
During the treatment period, indicators including liver function and blood routine need to be monitored, and the treatment plan should be adjusted in a timely manner.
Avoid unauthorized drug discontinuation
Even if symptoms are relieved, the treatment course must be completed as prescribed to prevent disease recurrence.
For further information on medication details or financial support, it is recommended to consult an oncology specialist outpatient clinic with relevant medical records.
